Venus Drugs And Cosmetics Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 21-12-2024
- Paid Up Capital ₹ 1.36 Cr
as on 21-12-2024
- Company Age 31 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 3.25 Cr
as on 21-12-2024
- Satisfied Charges ₹ 32.00 Cr
as on 21-12-2024
- Revenue 178.98%
(FY 2020)
- Profit 97.96%
(FY 2020)
- Ebitda -317.83%
(FY 2020)
- Net Worth -0.31%
(FY 2020)
- Total Assets 2.16%
(FY 2020)
About Venus Drugs And Cosmetics
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.36 Cr.
The company currently has active open charges totaling ₹3.25 Cr. The company has closed loans amounting to ₹32.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ritika Shah, Pritam Junnarkar, and Mahendra Shah serve as directors at the Company.
- CIN/LLPIN
U24231MH1993PLC073342
- Company No.
073342
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Aug 1993
- Date of AGM
15 Jan 2021
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Venus Drugs And Cosmetics Limited offer?
Venus Drugs And Cosmetics Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Beauty Cosmetics, Salon, Spa Kits & Equipments, Salon Consumables & Disposables, Aloe Vera Cosmetics, Aloe Vera Hair Conditioner, Body Scrubs, Face Scrub, Face Wash, Herbal Gel Face Wash.
Who are the key members and board of directors at Venus Drugs And Cosmetics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritika Shah  | Director | 07-Jun-2019 | Current |
| Pritam Junnarkar | Additional Director | 30-Aug-2021 | Current |
| Mahendra Shah | Additional Director | 06-Sep-2021 | Current |
Financial Performance of Venus Drugs And Cosmetics.
Venus Drugs And Cosmetics Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 178.98% increase. The company also saw a substantial improvement in profitability, with a 97.96% increase in profit. The company's net worth dipped by a decrease of 0.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venus Drugs And Cosmetics?
In 2020, Venus Drugs And Cosmetics had a promoter holding of 80.44% and a public holding of 19.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr Ritika's Research And Development Centre (Opc) Private LimitedActive 8 years 8 monthsRitika Shah is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Apr 2021 | ₹1.25 Cr | Open |
Others Creation Date: 29 Sep 2017 | ₹2.00 Cr | Open |
Bank Of Maharashtra Creation Date: 31 Dec 2013 | ₹13.00 Cr | Satisfied |
How Many Employees Work at Venus Drugs And Cosmetics?
Unlock and access historical data on people associated with Venus Drugs And Cosmetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venus Drugs And Cosmetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venus Drugs And Cosmetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
